Learn about the global non-animal alternatives testing market through The Business Research Company, which provides information on non-animal alternatives testing market size, non-animal alternatives testing market drivers and restraints, non-animal alternatives testing market players, the COVID-19 impact on the non-animal alternatives testing market, and more.

The global non-animal alternatives testing market is expected to grow from $1.63 billion in 2021 to $1.78 billion in 2022 at a compound annual growth rate (CAGR) of 9.08%. The growth in the non-animal alternatives testing market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The non-animal alternatives testing market is expected to reach $2.59 billion in 2026 at a CAGR of 9.83%.

The support from the government and non-governmental organisations boosts the growth of the non-animal testing market.

Request A Sample For The Global Non-Animal Alternatives Testing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2819&type=smp

The non-animal alternatives testing market consists of sales of non-animal alternatives testing products and services that do not involve testing on animals to determine the safety and efficacy of products and ingredients used in any industry sector. Non-animal alternative testing technologies include: in-vitro human cell and tissue cultures, organs-on-chips (OOCs), computer simulations and modelling (silico models), 3D bio-printing of tissues, and synthetic skin substitutes as well as studies with human volunteers. These technologies replace animal testing in end-use industries including pharmaceuticals, medical devices, chemicals & pesticides, food, and others.

Global Non-Animal Alternatives Testing Market Segments Include:

By Technology: Cell Culture Technology, High Throughput Technology, Molecular Imaging, Omics Technology

By Method: Cellular Assay, Biochemical Assay, In Silico, Ex-Vivo

By End-User: Pharmaceutical Industry, Cosmetics & Household Products, Diagnostics, Chemicals Industry, Food Industry

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America is the largest region in the global non-animal alternatives testing market in 2021.

OOCs (organs-on-chips) tool for testing is a major trend in the non-animal alternatives testing market. Organs-on-a-chips (OOCs) are miniature tissues and organs grown in-vitro that enable the modeling of human physiology and disease. OOCs are now being explored worldwide as tools for developing disease models and accurately predicting drug efficacies and toxicities. The advantages of OOCs over cell culture, animal models, and human clinical trials have captured the attention of both the medical and pharmaceutical communities focusing on developing targeted therapies.

TBRC’s non-animal alternatives testing market report covers:

Major Market Players: MatTek Corporation, Cyprotex, Emulate Inc, BioIVT, Bio-Rad Laboratories, GE Healthcare, SGS SA, BioIVT, Abbott Laboratories and Gentronix Limited.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)

The Non-Animal Alternatives Testing Global Market Report 2021: Market Size, Trends, And Global Forecast 2022 – 2026 is one of a series of new reports from The Business Research Company that provides non-animal alternatives testing market overviews, analyses and forecasts market size, share, non-animal alternatives testing market players, non-animal alternatives testing market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s non-animal alternatives testing market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Similar Reports From The Business Research Company:

Pharma Microbiology Testing Kits Global Market Report 2021

Food And Beverage Testing Kits Global Market Report 2021

Rapid Microbiology Testing Kits Global Market Report 2021

Interested To Know More About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: